SLE is characterized by impaired macrophage phagocytosis of ACs [1], delayed and proinflammatory AC clearance [2,3] and increased cellular expression of the type I IFN-inducible gene spectrum: the so-called IFN “signature” [25,26]. Here, IFNA1 is linked to systemic lupus erythematosus.